Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

Clinical trial NCT01007253 · COMPLETED

Trial details

NCT number: NCT01007253
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2009-11-01
Primary completion: 2010-04-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.